Takeda Pharmaceutical Company Limited (NYSE:TAK) Stake Trimmed by XY Capital Ltd

XY Capital Ltd lessened its stake in Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) by 52.2% in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 164,486 shares of the company's stock after selling 179,563 shares during the period. Takeda Pharmaceutical accounts for 0.8% of XY Capital Ltd's portfolio, making the stock its 16th biggest holding. XY Capital Ltd's holdings in Takeda Pharmaceutical were worth $2,339,000 as of its most recent filing with the Securities & Exchange Commission.

Several other large investors have also recently bought and sold shares of TAK. Millennium Management LLC boosted its holdings in shares of Takeda Pharmaceutical by 87.1% in the second quarter. Millennium Management LLC now owns 4,346,151 shares of the company's stock valued at $56,239,000 after acquiring an additional 2,023,707 shares in the last quarter. Cowen AND Company LLC bought a new position in Takeda Pharmaceutical during the 2nd quarter valued at $6,866,000. Van ECK Associates Corp increased its position in shares of Takeda Pharmaceutical by 21.1% during the 2nd quarter. Van ECK Associates Corp now owns 2,040,829 shares of the company's stock valued at $26,408,000 after purchasing an additional 356,069 shares during the period. Manning & Napier Advisors LLC bought a new stake in shares of Takeda Pharmaceutical in the 2nd quarter worth $4,098,000. Finally, Hantz Financial Services Inc. acquired a new stake in shares of Takeda Pharmaceutical in the second quarter valued at $2,843,000. Institutional investors and hedge funds own 9.17% of the company's stock.

Takeda Pharmaceutical Price Performance

TAK stock traded down $0.08 during trading hours on Friday, hitting $13.78. 984,229 shares of the stock traded hands, compared to its average volume of 1,829,672. The company has a current ratio of 1.28, a quick ratio of 0.77 and a debt-to-equity ratio of 0.64. The stock has a 50-day simple moving average of $14.38 and a 200 day simple moving average of $13.81. Takeda Pharmaceutical Company Limited has a one year low of $12.57 and a one year high of $15.08. The company has a market cap of $43.85 billion, a P/E ratio of 23.76, a P/E/G ratio of 0.26 and a beta of 0.54.

About Takeda Pharmaceutical

Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived therapies, immunology, oncology, and neuroscience.